Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed May 17, 2011
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Other
Common stock
2011-05-16$7.71/sh+1,484$11,441→ 93,044 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on May 16, 2011.